RAD001 and Erlotinib in Patients With Neuroendocrine Tumors
Clinical trial NCT00843531 · TERMINATED
Trial details
- NCT number
- NCT00843531
- Sponsor
- University of California, San Francisco
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-25
- Primary completion
- 2013-07-16
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.